NCT01919164 arm group 01d070b9a58597264c212855320ba137 [clinicaltrials_resource:NCT01919164/arm-group/01d070b9a58597264c212855320ba137]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01919164 arm group 01d070b9a58597264c212855320ba137 [clinicaltrials_resource:NCT01919164/arm-group/01d070b9a58597264c212855320ba137]
Bio2RDF identifier
NCT01919164/arm-group/01d070b9a58597264c212855320ba137
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... d070b9a58597264c212855320ba137
description [clinicaltrials_vocabulary:description]
AS902330 will be administered ...... ks, with follow-up to 2 years.
identifier
clinicaltrials_resource:NCT01919164/arm-group/01d070b9a58597264c212855320ba137
title
NCT01919164 arm group 01d070b9a58597264c212855320ba137
@en
type
label
NCT01919164 arm group 01d070b9 ...... 070b9a58597264c212855320ba137]
@en